DRUG-DRUG INTERACTIONS WITH THE USE OF PSYCHOTROPIC MEDICATIONS

被引：0
作者：
Sloan, Diane M.
Ereshefsky, Larry
机构：
来源：
CNS SPECTRUMS | 2009年 / 14卷 / 08期
关键词：
PLASMA-CONCENTRATIONS; CYP2D6; INHIBITION; ANTIDEPRESSANT; METABOLISM; FLUOXETINE; PHARMACOLOGY; DEXTROMETHORPHAN; FLUVOXAMINE; RISPERIDONE; VENLAFAXINE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1 / 8
页数：8
相关论文
共 55 条
  • [31] McDonald Amy A, 2006, J Support Oncol, V4, P43
  • [32] SURVEY ON THE PHARMACODYNAMICS OF THE NEW ANTIPSYCHOTIC RISPERIDONE
    MEGENS, AAHP
    AWOUTERS, FHL
    SCHOTTE, A
    MEERT, TF
    DUGOVIC, C
    NIEMEGEERS, CJE
    LEYSEN, JE
    [J]. PSYCHOPHARMACOLOGY, 1994, 114 (01) : 9 - 23
  • [33] Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study
    Michelson, D
    Faries, D
    Wernicke, J
    Kelsey, D
    Kendrick, K
    Sallee, FR
    Spencer, T
    [J]. PEDIATRICS, 2001, 108 (05) : E83
  • [34] Which antidepressants have demonstrated superior efficacy?: A review of the evidence
    Montgomery, Stuart A.
    Baldwin, David S.
    Blier, Pierre
    Fineberg, Naomi A.
    Kasper, Siegfried
    Lader, Malcolm
    Lam, Raymond W.
    Lepine, Jean-Pierre
    Moeller, Hans-Juergen
    Nutt, David J.
    Rouillon, Frederic
    Schatzberg, Alan F.
    Thase, Michael E.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (06) : 323 - 329
  • [35] Nemeroff CB, 2007, CNS SPECTRUMS, V12, P4
  • [36] OHON SV, 1993, CLIN PHARMACOL THER, V54, P463
  • [37] SUCRALFATE REDUCES THE GASTROINTESTINAL ABSORPTION OF NORFLOXACIN
    PARPIA, SH
    NIX, DE
    HEJMANOWSKI, LG
    GOLDSTEIN, HR
    WILTON, JH
    SCHENTAG, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) : 99 - 102
  • [38] MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression
    Peles, Alma Mihaljevic
    Bozina, Nada
    Sagud, Marina
    Kuzman, Martina Rojnic
    Lovric, Mila
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06) : 1439 - 1444
  • [39] Performance of drug-drug interaction software for personal digital assistants
    Perkins, Natalie A.
    Murphy, John E.
    Malone, Daniel C.
    Armstrong, Edward P.
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 850 - 855
  • [40] PERRY PJ, 1994, J CLIN PSYCHOPHARM, V14, P230
123456